
Effect of 5-aza-2ˈ-deoxycytidine on p27Kip1, p21Cip1/Waf1/Sdi1, p57Kip2, and DNA methyltransferase 1 Genes Expression, Cell Growth Inhibition and Apoptosis Induction in Colon Cancer SW 480 and SW 948 Cell Lines
Background: Dysregulation of the cell cycle has been reported in various cancers. Inactivation of the cyclin-dependent kinases inhibitors (CDKIs), CIP/KIP family, such as p21Cip1/Waf1/Sdi1, p27Kip1, and p57Kip2 genes because of hypermethylation has been shown in several cancers. Treatment with DNA demethylating agent 5-aza-2ˈ-deoxycytidine (5-Aza-CdR) has been indicated that affect genomic methylation and resulting in silenced genes reactivation in colon cancer. Previously, we evaluated the effect of 5-Aza-CdR on DNA methyltransferase 1 (DNMT1) gene expression in hepatocellular carcinoma (HCC) which encouraged us to design the current study. The present study aimed to evaluate the effect of 5-Aza-CdR on p21Cip1/Waf1/Sdi1, p27Kip1, p57Kip2, and DNAT1 genes expression, cell growth inhibition and apoptosis induction in colon cancer SW 480 and SW 948 cell lines. Materials and Methods: The effect of 5-aza-CdR on the SW 480 and SW 948 cells growth, apoptosis induction and genes expression were assessed by MTT assay, flow cytometry, and real-time quantitative reverse transcription-polymerase chain reaction (qRT-PCR) analysis respectively. Results: 5-aza-CdR inhibited cell growth as time- and dose-dependent manner significantly (P<0.001). The agent reactivated p15INK4, p16INK4, p18INK4, and p19INK4 genes expression and induced apoptosis at a concentration of 5 μM significantly. Besides, 5-aza-CdR had a more significant effect on the SW 480 cell line in comparison to SW 948 cell line. Conclusion: 5-Aza-CdR plays a key role in the up-regulation of p21Cip1/Waf1/Sdi1, p27Kip1, and p57Kip2 and down-regulation of DNMT1 genes resulting in cell growth inhibition and apoptosis induction. [GMJ.2020;9:e1899] DOI:10.31661/gmj.v9i0.1899
Park M-T, Lee S-J. Cell cycle and cancer. J. Biochem. Mol. Biol. 2003; 36(1):60-5.
https://doi.org/10.5483/BMBRep.2003.36.1.060
PMid:12542976
Williams GH, Stoeber K. The cell cycle and cancer. The Journal of pathology. 2012; 226(2):352-64.
https://doi.org/10.1002/path.3022
PMid:21990031
Collins I, Garrett MD. Targeting the cell division cycle in cancer: CDK and cell cycle checkpoint kinase inhibitors. Curr Opin Pharm. 2005; 5(4):366-73.
https://doi.org/10.1016/j.coph.2005.04.009
PMid:15964238
Malumbres M. Cyclin-dependent kinases. Genome Biol. 2014; 15(6):122.
https://doi.org/10.1186/gb4184
PMid:25180339 PMCid:PMC4097832
Lu R, Wang X, Chen Z-F, Sun D-F, Tian X-Q, Fang J-Y. Inhibition of the extracellular signal-regulated kinase/mitogen-activated protein kinase pathway decreases DNA methylation in colon cancer cells. J Biol Chem. 2007; 282(16):12249-59.
https://doi.org/10.1074/jbc.M608525200
PMid:17307743
Das PM, Singal R. DNA methylation and cancer. J Clin Oncol. 2004; 22(22):4632-42.
https://doi.org/10.1200/JCO.2004.07.151
PMid:15542813
Roulois D, Yau HL, Singhania R, Wang Y, Danesh A, Shen SY, et al. DNA-demethylating agents target colorectal cancer cells by inducing viral mimicry by endogenous transcripts. Cell 2015; 162(5):961-73.
https://doi.org/10.1016/j.cell.2015.07.056
PMid:26317465 PMCid:PMC4843502
Mossman D, Kim K-T, Scott RJ. Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists. BMC Cancer. 2010; 10(1):366
https://doi.org/10.1186/1471-2407-10-366
PMid:20618997 PMCid:PMC2912869
Zhu W-G, Hileman T, Ke Y, Wang P, Lu S, Duan W, et al. 5-aza-2′-deoxycytidine activates the p53/p21Waf1/Cip1 pathway to inhibit cell proliferation. J Biol Chem. 2004; 279(15):15161-6.
https://doi.org/10.1074/jbc.M311703200
PMid:14722112
Bott S, Arya M, Kirby R, Williamson M. p21 WAF1/CIP1 gene is inactivated in metastatic prostatic cancer cell lines by promoter methylation. Prostate Cancer Prostatic Dis. 2005; 8(4):321.
https://doi.org/10.1038/sj.pcan.4500822
PMid:16276353
Ling Y, Zhang C, Xu Y, Zhu J, Zhu C, Lu M, et al. Promoter methylation‑associated silencing of p27kip1 gene with metastasis in esophageal squamous cell carcinoma. Mol Med Report. 2014; 9(3):1075-9
https://doi.org/10.3892/mmr.2014.1887
PMid:24402707
Kobatake T, Yano M, Toyooka S, Tsukuda K, Dote H, Kikuchi T, et al. Aberrant methylation of p57KIP2 gene in lung and breast cancers and malignant mesotheliomas. Oncol Rep. 2004; 12(5):1087-92.
https://doi.org/10.3892/or.12.5.1087
PMid:15492797
Sanaei M, Kavoosi F. Effects of 5-aza-2'-deoxycytidine and Valproic Acid on Epigenetic-modifying DNMT1 Gene Expression, Apoptosis Induction and Cell Viability in Hepatocellular Carcinoma WCH-17 cell line. Iranian Journal of Pediatric Hematology & Oncology. 2019; 9(2).
https://doi.org/10.18502/ijpho.v9i2.607
Sanaei M, Kavoosi F, Roustazadeh A, Golestan F. Effect of Genistein on DNMT1Gene Expression and Cell Proliferation of Hepatocellular Carcinoma HepG2 Cell Line. Global Journal of Medicine Researches and Studies. 2017; 4(1).
Sanaei M, Kavoosi F, Roustazadeh A, Golestan F. Effect of genistein in comparison with trichostatin a on reactivation of DNMTs genes in hepatocellular carcinoma. Journal of clinical and translational hepatology. 2018; 6(2):141.
https://doi.org/10.14218/JCTH.2018.00002
PMid:29951358 PMCid:PMC6018304
Gao F-H, Hu X-H, Li W, Liu H, Zhang Y-J, Guo Z-Y, et al. Oridonin induces apoptosis and senescence in colorectal cancer cells by increasing histone hyperacetylation and regulation of p16, p21, p27 and c-myc. BMC Cancer. 2010; 10(1):610.
https://doi.org/10.1186/1471-2407-10-610
PMid:21054888 PMCid:PMC2992521
Oya M, Schulz W. Decreased expression of p57 KIP2 mRNA in human bladder cancer. Br. J. Cancer. 2000; 83(5):626.
https://doi.org/10.1054/bjoc.2000.1298
PMid:10944603 PMCid:PMC2363522
Chim C, Wong A, Kwong Y. Epigenetic inactivation of the CIP/KIP cell-cycle control pathway in acute leukemias. Am J Hematol. 2005; 80(4):282-7.
https://doi.org/10.1002/ajh.20503
PMid:16315255
Brakensiek K, Länger F, Kreipe H, Lehmann U. Absence of p21CIP1, p27KIP1 and p57KIP2 methylation in MDS and AML. Leukemia Res. 2005; 29(11):1357-60.
https://doi.org/10.1016/j.leukres.2005.04.012
PMid:15936816
Xu X-L, Yu J, Zhang H-Y, Sun M-H, Gu J, Du X, et al. Methylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis. World journal of gastroenterology: WJG. 2004; 10(23):3441.
https://doi.org/10.3748/wjg.v10.i23.3441
PMid:15526363 PMCid:PMC4576225
Peng Y-T, Wu W-R, Chen L-R, Kuo K-K, Tsai C-H, Huang Y-T, et al. Upregulation of cyclin-dependent kinase inhibitors CDKN1B and CDKN1C in hepatocellular carcinoma-derived cells via goniothalamin-mediated protein stabilization and epigenetic modifications. Toxicology reports. 2015; 2:322-32.
https://doi.org/10.1016/j.toxrep.2015.01.010
PMid:28962365 PMCid:PMC5598353
Zhao Y, Li Q, Wu X, Chen P. Upregulation of p27Kip1 by demethylation sensitizes cisplatin-resistant human ovarian cancer SKOV3 cells. Mol Med Report. 2016; 14(2):1659-66.
https://doi.org/10.3892/mmr.2016.5399
PMid:27314502
Lee K-H, Lotterman C, Karikari C, Omura N, Feldmann G, Habbe N, et al. Epigenetic silencing of MicroRNA miR-107 regulates cyclin-dependent kinase 6 expression in pancreatic cancer. Pancreatology. 2009; 9(3):293-301.
https://doi.org/10.1159/000186051
PMid:19407485 PMCid:PMC2835374
Schneider-Stock R, Diab-Assef M, Rohrbeck A, Foltzer-Jourdainne C, Boltze C, Hartig R, et al. RETRACTION: 5-aza-Cytidine Is a Potent Inhibitor of DNA Methyltransferase 3a and Induces Apoptosis in HCT-116 Colon Cancer Cells via Gadd45-and p53-Dependent Mechanisms. J Pharmacol Exp Ther. 2005; 312(2):525-36.
https://doi.org/10.1124/jpet.104.074195
PMid:15547111
Tao S-F, Zhang C-S, Guo X-L, Xu Y, Zhang S-S, Song J-R, et al. Anti-tumor effect of 5-aza-2'-deoxycytidine by inhibiting telomerase activity in hepatocellular carcinoma cells. World journal of gastroenterology: WJG. 2012; 18(19):2334.
https://doi.org/10.3748/wjg.v18.i19.2334
PMid:22654424 PMCid:PMC3353367
Bott S, Arya M, Kirby R, Williamson M. p21 WAF1/CIP1 gene is inactivated in metastatic prostatic cancer cell lines by promoter methylation. Prostate Cancer Prostatic Dis. 2005;8(4):321.
https://doi.org/10.1038/sj.pcan.4500822
PMid:16276353
WANG H-l, ZHANG J, LI Y, WANG X-q. Experimental studies of 5-Aza-CdR on p27kip1 gene's abnormal methylation in gastric cancer cell line [J]. Practical Pharmacy and Clinical Remedies. 2011; 2.
Kobatake T, Yano M, Toyooka S, Tsukuda K, Dote H, Kikuchi T, et al. Aberrant methylation of p57KIP2 gene in lung and breast cancers and malignant mesotheliomas. Oncol Rep. 2004;12(5):1087-92.
https://doi.org/10.3892/or.12.5.1087
PMid:15492797
Sandal T. Molecular aspects of the mammalian cell cycle and cancer. The oncologist. 2002;7(1):73-81.
https://doi.org/10.1634/theoncologist.7-1-73
PMid:11854549
Cheetham S, Tang M, Mesak F, Kennecke H, Owen D, Tai I. SPARC promoter hypermethylation in colorectal cancers can be reversed by 5-Aza-2′ deoxycytidine to increase SPARC expression and improve therapy response. Br J Cancer. 2008;98(11):1810.
https://doi.org/10.1038/sj.bjc.6604377
PMid:18458674 PMCid:PMC2410109
Wang L-S, Kuo C-T, Cho S-J, Seguin C, Siddiqui J, Stoner K, et al. Black raspberry-derived anthocyanins demethylate tumor suppressor genes through the inhibition of DNMT1 and DNMT3B in colon cancer cells. Nutr Cancer. 2013;65(1):118-25.
https://doi.org/10.1080/01635581.2013.741759
PMid:23368921 PMCid:PMC3570951
Hsi LC, Xi X, Wu Y, Lippman SM. The methyltransferase inhibitor 5-aza-2-deoxycytidine induces apoptosis via induction of 15-lipoxygenase-1 in colorectal cancer cells. Mol Cancer Ther. 2005;4(11):1740-6.
https://doi.org/10.1158/1535-7163.MCT-05-0218
PMid:16275995
Kaminski R, Kozar K, Niderla J, Grzela T, Wilczynski G, Skierski JS, et al. Demethylating agent 5-aza-2'-deoxycytidine enhances expression of TNFRI and promotes TNF-mediated apoptosis in vitro and in vivo. Oncol Rep. 2004;12(3):509-16.
https://doi.org/10.3892/or.12.3.509
PMid:15289829
Yu J, Ma X, Cheung K, Li X, Tian L, Wang S, et al. Epigenetic inactivation of T-box transcription factor 5, a novel tumor suppressor gene, is associated with colon cancer. Oncogene. 2010; 29(49):6464.
https://doi.org/10.1038/onc.2010.370
PMid:20802524
Satoh A, Toyota M, Itoh F, Kikuchi T, Obata T, Sasaki Y, et al. DNA methylation and histone deacetylation associated with silencing DAP kinase gene expression in colorectal and gastric cancers. Br J Cancer. 2002; 86(11):1817.
https://doi.org/10.1038/sj.bjc.6600319
PMid:12087472 PMCid:PMC2375414
Refbacks
- There are currently no refbacks.